Literature DB >> 15010107

Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.

Kunihiko Teraoka1, Masaharu Hirano, Hiroyuki Ookubo, Kazuyoshi Sasaki, Hiroaki Katsuyama, Masayuki Amino, Yimihiko Abe, Akira Yamashina.   

Abstract

Fibrotic lesions in the myocardium exhibit delayed contrast enhancement (DCE) on MR images. On the other hand, plexiform fibrosis is observed in hypertrophic cardiomyopathy (HCM), indicating an association of this condition with the pathogenesis of heart failure and arrhythmia. To examine the occurrence and extent of DCE and its relation to cardiac function and arrhythmia in HCM, we studied 59 patients with HCM who had undergone MRI. The relationship of DCE to cardiac function and arrhythmia was further investigated. DCE occurred in 45 (76.3%) of the 59 patients with HCM, with a high frequency of localization in regions, where the right ventricle is attached. As for the relationship of DCE to cardiac function, a significant decrease (P=0.007) in cardiac function was observed in the group in which 4 or more segments exhibited DCE, compared with the group in which DCE was observed in 3 or less segments. Regarding the relationship of DCE to arrhythmia, both the occurrence of DCE and the extent of DCE were significantly larger (p<0.05, p=0.026, respectively) in the group with VT. These results indicate that DCE may save to identify severe cases of HCM on the basis of cardiac function, arrhythmia, and pathophysiological aspects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15010107     DOI: 10.1016/j.mri.2003.08.009

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  40 in total

1.  Late gadolinium enhancement gray zone in patients with hypertrophic cardiomyopathy. Comparison of different gray zone definitions.

Authors:  Mateusz Spiewak; Lukasz A Małek; Lidia Chojnowska; Jolanta Miśko; Joanna Petryka; Mariusz Kłopotowski; Barbara Milosz; Magdalena Polańska; Witold Ruzyłło
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-27       Impact factor: 2.357

Review 2.  Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity.

Authors:  Toru Kubo; Hiroaki Kitaoka
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

3.  Delayed Myocardial Enhancement in Pediatric Hypertrophic Cardiomyopathy: Correlation with LV Function, Echocardiography, and Demographic Parameters.

Authors:  Sonia El Saiedi; Noha Hossam Behairy; Ahmed Kharabish; Reem Esmail; Zeinab Salah Seliem; Mervat Shafik; Wesam El Mozy
Journal:  Pediatr Cardiol       Date:  2017-04-11       Impact factor: 1.655

4.  Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Authors:  Elif Elmas; Christina Doesch; Stephan Fluechter; Miriam Freundt; Christel Weiss; Siegfried Lang; Thorsten Kälsch; Dariush Haghi; Jana Papassotiriou; Jan Kunde; Stefan O Schoenberg; Martin Borggrefe; Theano Papavassiliu
Journal:  Int J Cardiovasc Imaging       Date:  2010-09-26       Impact factor: 2.357

5.  Editorial. Hypertrophic Cardiomyopathy with ventricular tachycardia.

Authors:  Deborah H Kwon; Milind Y Desai
Journal:  Int J Cardiovasc Imaging       Date:  2007-06-01       Impact factor: 2.357

6.  Improved diagnosis of arrhythmogenic right ventricular dysplasia.

Authors:  Karam Souibri; Gerald M Pohost
Journal:  Curr Cardiol Rep       Date:  2006-03       Impact factor: 2.931

Review 7.  Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.

Authors:  Annamalai Senthilkumar; Maulik D Majmudar; Chetan Shenoy; Han W Kim; Raymond J Kim
Journal:  Heart Fail Clin       Date:  2009-07       Impact factor: 3.179

8.  Cardiac MRI and CT features of inheritable and congenital conditions associated with sudden cardiac death.

Authors:  Patrick Sparrow; Naeem Merchant; Yves Provost; Deirdre Doyle; Elsie Nguyen; Narinder Paul
Journal:  Eur Radiol       Date:  2008-09-16       Impact factor: 5.315

9.  High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy.

Authors:  Yasuki Hen; Nobuo Iguchi; Haruhiko Machida; Kaori Takada; Yuko Utanohara; Tetsuya Sumiyoshi
Journal:  Heart Vessels       Date:  2012-10-25       Impact factor: 2.037

10.  Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study.

Authors:  Deborah H Kwon; Randolph M Setser; Zoran B Popović; Maran Thamilarasan; Srikanth Sola; Paul Schoenhagen; Mario J Garcia; Scott D Flamm; Harry M Lever; Milind Y Desai
Journal:  Int J Cardiovasc Imaging       Date:  2008-01-19       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.